- Home
- CMND vs ACON Comparison
CMND vs ACON Comparison
Compare CMND & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMND
- ACON
- Stock Information
- Founded
- CMND 2017
- ACON 2008
- Country
- CMND Canada
- ACON United States
- Employees
- CMND N/A
- ACON N/A
- Industry
- CMND Biotechnology: Pharmaceutical Preparations
- ACON Retail: Computer Software & Peripheral Equipment
- Sector
- CMND Health Care
- ACON Technology
- Exchange
- CMND Nasdaq
- ACON Nasdaq
- Market Cap
- CMND 6.0M
- ACON 4.8M
- IPO Year
- CMND N/A
- ACON 2022
- Fundamental
- Price
- CMND $0.98
- ACON $7.64
- Analyst Decision
- CMND
- ACON Buy
- Analyst Count
- CMND 0
- ACON 2
- Target Price
- CMND N/A
- ACON $481.00
- AVG Volume (30 Days)
- CMND 571.2K
- ACON 75.1K
- Earning Date
- CMND 06-12-2025
- ACON 04-09-2025
- Dividend Yield
- CMND N/A
- ACON N/A
- EPS Growth
- CMND N/A
- ACON N/A
- EPS
- CMND N/A
- ACON N/A
- Revenue
- CMND N/A
- ACON $45,724.00
- Revenue This Year
- CMND N/A
- ACON $251.35
- Revenue Next Year
- CMND N/A
- ACON N/A
- P/E Ratio
- CMND N/A
- ACON N/A
- Revenue Growth
- CMND N/A
- ACON N/A
- 52 Week Low
- CMND $0.85
- ACON $7.26
- 52 Week High
- CMND $2.30
- ACON $6,241.05
- Technical
- Relative Strength Index (RSI)
- CMND 43.62
- ACON 33.40
- Support Level
- CMND $0.95
- ACON $8.15
- Resistance Level
- CMND $1.18
- ACON $8.30
- Average True Range (ATR)
- CMND 0.09
- ACON 1.25
- MACD
- CMND 0.01
- ACON 6.41
- Stochastic Oscillator
- CMND 39.39
- ACON 6.94
About CMND Clearmind Medicine Inc.
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.
About ACON Aclarion Inc.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.